ENS:NYSEEnerSys Analysis
Data as of 2026-09-04 - not real-time
$179.99
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
EnerSys trades at $179.99, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it lost 10.0%. With RSI at 37.5 the momentum picture is approaching oversold, alongside a bearish MACD signal. Watch $177.12 as support and $217.00 as the nearer resistance level.
Multiples put this in undervalued territory: 19.3 times earnings against the sector's 28.3. Analyst price targets sit 40.3% above the current price. Revenue is growing at 4.8% on a 9.3% profit margin.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 39.6%, a beta of 1.74 and a maximum drawdown of 27.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.
Multiples put this in undervalued territory: 19.3 times earnings against the sector's 28.3. Analyst price targets sit 40.3% above the current price. Revenue is growing at 4.8% on a 9.3% profit margin.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 39.6%, a beta of 1.74 and a maximum drawdown of 27.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.
Top Market Events
EnerSys stock has more than doubled over the past five years, and after the latest earnings-driven jump the key...Shares of battery manufacturer EnerSys NYSE:ENS jumped 5.Battery manufacturer EnerSys NYSE:ENS reported Q2 CY2026 results , with sales up 4.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 185.97
- MACD momentum is negative
- 30-day price change of -10.0%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 19.3 versus sector average of 28.3
- Trading below the 200-day average of 185.97
- Analyst targets imply +40.3% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 19.3 versus sector average of 28.3
- Analyst targets imply +40.3% versus the current price
- Return on equity of 18.4%
Key Metrics & Analysis
Financial Health
Revenue Growth4.80%
Profit Margin9.29%
P/E Ratio19.3
ROE18.36%
ROA7.84%
Debt/Equity56.11
P/B Ratio3.3
Op. Cash Flow$776.8M
Free Cash Flow$614.7M
Industry P/E28.3
Technical Analysis
TrendNeutral
RSI37.5
Support$177.12
Resistance$217.00
MA 20$190.23
MA 50$196.44
MA 200$185.97
MACDBearish
VolumeDecreasing
Fear & Greed Index96
Valuation
Fair Value$248.19
Target Price$252.58
Upside/Downside40.33%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.74
Volatility39.65%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.